BILL · 2021–22 SESSION
HB 1713: Rx drug cost sharing
Requiring cost sharing for prescription drugs to be counted against an enrollee's obligation, regardless of source.
Did not pass Did not pass · died in committee
- IntroducedJan 10, 2022
- Out of committeestopped here
- Passed House
- Passed Senate
- Governor
- Law
- Prime sponsor
- My-Linh Thai (D-41)
- Introduced
- January 10, 2022 in the House
- Last action
- January 10, 2022
- Companion bill
- SB 5610
AN ACT Relating to requiring cost sharing for prescription drugs to be counted against an enrollee's out-of-pocket costs, deductible, cost sharing, out-of-pocket maximum, or similar enrollee obligation, regardless of the source of the payment;
Sponsors
Prime sponsor: My-Linh Thai (D-41)
7 co-sponsors (7 Democrats, 0 Republicans)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- First reading, referred to Health Care & Wellness.
- Prefiled for introduction.
HB 1713 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- HB 1713 (2025–26) Automatic voter reg./tribes
- HB 1713 (2023–24) Health care/rural areas
- HB 1713 (2019–20) Native American women
- HB 1713 (2017–18) Children's mental health
- HB 1713 (2015–16) Mental hlth, chem dependency
- HB 1713 (2013–14) Medicaid waiver/benefit exch
- HB 1713 (2011–12) SEPA categorical exemptions
- HB 1713 (2009–10) State health insurance pool